Share of adolescent girls vaccinated against human papillomavirus in Israel

Israel: Share of adolescent girls vaccinated against human papillomavirus was 55.0% in 2024. ▲ Rising

Latest (2024)
55.0%
Change on year
up 1.9%
World rank
45th
of 74 countries
All-time high
58.0%
in 2022
All-time low
50.0%
in 2019
Years of data
9
2016–2024

Share of adolescent girls vaccinated against human papillomavirus in Israel, 2016–2024

02040602016202020242016: 51 %2017: 52 %2018: 57 %2019: 50 %2020: 52 %2021: 54 %2022: 58 %2023: 54 %2024: 55 %

Source: WHO & UNICEF (2025) – processed by Our World in Data. Measured in %.

Analysis

Israel recorded 55.0% for share of adolescent girls vaccinated against human papillomavirus in 2024.

Compared with earlier readings it is up 1.9% on the previous year and up 7.8% over ten years.

Over the whole period, share of adolescent girls vaccinated against human papillomavirus in Israel peaked at 58.0% in 2022 and was at its lowest, 50.0%, in 2019.

Israel ranks 45th of 74 countries on this measure, in the middle of the range.

Share of adolescent girls vaccinated against human papillomavirus in Israel, year by year

Annual values for Share of adolescent girls vaccinated against human papillomavirus in Israel, 2016 to 2024.
Year % Change
2016 51.0%
2017 52.0% +2.0%
2018 57.0% +9.6%
2019 50.0% -12.3%
2020 52.0% +4.0%
2021 54.0% +3.8%
2022 58.0% +7.4%
2023 54.0% -6.9%
2024 55.0% +1.9%

Averages by decade

DecadeAverage LowestHighest Years
2010s 52.5% 50.0% 57.0% 4
2020s 54.6% 52.0% 58.0% 5

Countries ranked near Israel

  1. 44 Slovenia 61.0% compare
  2. 45 Germany 55.0% compare
  3. 45 Italy 55.0% compare
  4. 45 Suriname 55.0% compare

See the full ranking of 74 places →

More health data for Israel

All data for Israel →

Frequently asked questions

What is share of adolescent girls vaccinated against human papillomavirus in Israel?
Share of adolescent girls vaccinated against human papillomavirus in Israel was 55.0% in 2024, according to WHO & UNICEF (2025) – processed by Our World in Data.
What is the highest share of adolescent girls vaccinated against human papillomavirus recorded in Israel?
The highest recorded value was 58.0% in 2022.
What is the lowest share of adolescent girls vaccinated against human papillomavirus recorded in Israel?
The lowest recorded value was 50.0% in 2019.
How does Israel rank for share of adolescent girls vaccinated against human papillomavirus?
Israel ranks 45th out of 74 countries with data for 2024.
Is share of adolescent girls vaccinated against human papillomavirus rising or falling in Israel?
Over the last ten years it is up 7.8%. The long-run trend across the full record is rising.
Where does this Israel data come from?
The figures come from WHO & UNICEF (2025) – processed by Our World in Data, published as part of Share of adolescent girls vaccinated against human papillomavirus. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of adolescent girls vaccinated against human papillomavirus in Israel. Statizoid, drawing on WHO & UNICEF (2025) – processed by Our World in Data. Retrieved 01 September 2026, from https://health.statizoid.com/stat/coverage-of-the-human-papillomavirus-vaccine/israel/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/coverage-of-the-human-papillomavirus-vaccine/israel/">Share of adolescent girls vaccinated against human papillomavirus in Israel</a> — Statizoid

About this data

Indicator
Share of adolescent girls vaccinated against human papillomavirus
Unit
%
Source
WHO & UNICEF (2025) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
74 places, 719 data points, 2010–2024
Last refreshed

Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.